Search - tctmd.com

Displaying 21 - 40 of 45

Sort: Relevancy | Date

News Daily News

Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement

Yael L. Maxwell

April 26, 2021

News Daily News

Women Treated for Acute HF Report Worse QoL Than Men

Caitlin E. Cox

March 12, 2021

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

Endovascular Stroke Therapy Less Beneficial After Transfer

Caitlin E. Cox

August 27, 2020

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

News Conference News ISET 2020

Values-Based Outpatient Care: Put Patients First Even When No One’s Watching

Caitlin E. Cox

February 05, 2020

News Daily News

STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France

Michael O'Riordan

October 31, 2019

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Caitlin E. Cox

June 13, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Daily News

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

Yael L. Maxwell

November 01, 2018

News Daily News

New BMJ Guidance Urges Prudence With Supplemental Oxygen, Especially in Acute MI, Stroke

Yael L. Maxwell

October 25, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

News Daily News

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

Todd Neale

September 11, 2018

News Opinion Fellow Talk

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

Yashasvi Chugh, MD

August 16, 2018

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

Advertisement

Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement

Women Treated for Acute HF Report Worse QoL Than Men

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Endovascular Stroke Therapy Less Beneficial After Transfer

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Values-Based Outpatient Care: Put Patients First Even When No One’s Watching

STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

New BMJ Guidance Urges Prudence With Supplemental Oxygen, Especially in Acute MI, Stroke

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

Discharge Against Medical Advice After PCI Rare but Deadly

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content